James Edward Bass, Director at REATA PHARMACEUTICALS INC (RETA), bought 24,448 shares at $13.28 ($264K) on 2016-06-01, disclosed to the SEC on 2016-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,448 | $0 | 0.0% |
| 2 | $11.00 | 18,000 | $198K | 74.9% |
| 3 | $13.28 | 5,000 | $66K | 25.1% |
| Total | $10.81 avg | 24,448 | $264K | 100% |
| Filing → |
| RETA | BUY | 2018-11-19 | $199K | — | Filing → |
| RETA | BUY | 2018-07-26 | $139K | — | Filing → |
| RETA | BUY | 2017-11-16 | $187K | — | Filing → |